Mounjaro and Zepbound are two brand-name glucagon-like peptide-1 (GLP-1) medications manufactured by Eli Lilly. Although they ...
The once‑weekly “triple hormone” injection outperformed blockbuster drugs like Wegovy and Zepbound but caused more ...
A Cleveland Clinic study suggests GLP-1 weight loss drugs may help slow the spread of some obesity-related cancers.
Big shifts GLP-1 market include FDA approval of oral weight loss drugs and expanded Medicare coverage starting July 2024 for key GLP-1 therapies.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results